Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Amedisys, Inc. (NASDAQ: AMED) to Optum for $101.00 per share is fair to Amedisys shareholders. Halper Sadeh encourages Amedisys shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or
[email protected] or
[email protected] . The investigation concerns whether Amedisys and its board of directors violated the federal...